N/A N=2 Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19
COVID-19
Primary: Oxygen Saturation by Pulse Oximetry — 92; 93.5; 94; 94 percentage of oxygen saturation
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=60 Platelet Rich Fibrin vs Sub Epithelial Connective Tissue and Coronally Advanced Flap Alone in Gingival Recession
Gingival Recession
Primary: Gingival Thickness — 1.97; 1.95; 1.39 millimeter
Phase 4 N=6 Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks
Multiple Sclerosis
Primary: Participants Who Experienced at Least One Qualifying Cardiovascular Adverse Event — 0 participants
N/A N=305 Electronic Repositioning With Acuity and Easytrak Leads
Heart Failure
Primary: Proportion of Patients Without the Occurrence of Cardiac Resynchronization Therapy (CRT)-Induced Phrenic Nerve Stimulation (PNS) Between Implant and First Regular…
Phase 2 N=50 Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia
Primary: Best Response Rate — 26 Participants
Phase 2 N=8 Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART
Human Immunodeficiency Virus (HIV)
Primary: Primary Outcome Measure — 1; 2 Participants
N/A N=45 755nm Alex Laser for Treatment of Stretch Marks
Striae
Primary: Photographic Evaluation of Striae Clearance — 36; 17; 11 areas with striation
N/A N=1 Prostate Cancer Screening in Men With Germline BRCA2 Mutations
Prostate Cancer
Primary: Number of Prostate Cancer Patients With BRCA2 Mutation Carriers — 0 participants
Phase 2 N=979 A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adults 18 to 40 Years of Age
Infections, Meningococcal
Primary: Adjusted Human Serum Bactericidal Activity (hSBA) Geometric Mean Titers (GMTs) Against N. Meningitidis Serogroup A for Each Vaccine Group, and Between-group Ratios…
Phase 2 N=200 Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease
Clostridium Infections
Primary: Number of Participants With Recurrence of Clostridium Difficile Associated Disease (CDAD) — 7; 25 Participants
N/A N=63 Picosure Alexandrite Laser and Revlite Nd:Yag Laser for the Treatment of Unwanted Tattoos
Unwanted Tattoos
Primary: Tattoo Clearance — 2.5; 3.0 score on a scale
Phase 2 N=32 Neoadjuvant Therapy for Ovarian Cancer
Epithelial Ovarian Cancer · Primary Peritoneal Cancer · Fallopian Tube Cancer
Primary: Number of Protocol Defined Adverse Events in Patients Receiving Neoadjuvant Carboplatin, Paclitaxel, and Bevacizumab — 7 protocol defined adverse events
Phase 2 N=296 A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Primary: Change From Baseline in HbA1c to Week 26 — -0.663; -1.517; -1.618; -1.562 percentage of HbA1c — p=< 0.0001
Phase 2 N=54 Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma
Adult Alveolar Soft Part Sarcoma · Adult Angiosarcoma · Adult Desmoplastic Small Round Cell Tumor
Primary: Progression-free Survival (PFS) — 4.5; 1.6; 8.9; 1.5 months — p=0.017
N/A N=245 Tissue Oxygenation During Treatment of Infant Congenital Heart Defects
Acute Kidney Injury · Hypoxia-Ischemia, Brain · Mesenteric Ischemia
Primary: Number of Participants With Acute Kidney Injury — 18; 57 Participants